# BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment

> **NCT00005611** · PHASE1 · UNKNOWN · sponsor: **H. Lee Moffitt Cancer Center and Research Institute**

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** BMS-188797

## Key facts

- **NCT ID:** NCT00005611
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2008-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005611, "BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00005611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*